#United States #New York #Monteverde Associates #DAWN #SEM

Monteverde & Associates Investigates Merger Transactions

In a significant development for shareholders involved with several companies, the M&A Class Action Firm, led by attorney Juan Monteverde, is investigating mergers affecting Day One Biopharmaceuticals, Select Medical Holdings Corporation, FONAR Corporation, and Janus Henderson Group plc. With a recognized track record, Monteverde & Associates is at the forefront of shareholder advocacy, working to protect the interests of stockholders involved in these upcoming transactions.

Investigated Companies and Transactions

1. Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
The firm is currently reviewing the proposed sale of Day One to Servier Pharmaceuticals LLC, which puts forward the purchase price of $21.50 per share for its shareholders. Monteverde & Associates is dedicated to ensuring that shareholders receive fair compensation from this transaction.

2. Select Medical Holdings Corporation (NYSE: SEM)
In another intriguing case, Select Medical is set to be sold to a consortium led by its executives and directors. Shareholders are expected to receive $16.50 in cash per share. Monteverde & Associates is poised to analyze this acquisition closely to ensure shareholders' rights are protected.

3. FONAR Corporation (NASDAQ: FONR)
This investigation extends to FONAR, whose proposed transaction involves selling to affiliates of CEO Timothy Damadian along with some of its executives and directors. The upcoming arrangement proposes a payout of $19.00 per share for Class B common stockholders and $6.34 for Class C common stockholders.

4. Janus Henderson Group plc (NYSE: JHG)
Lastly, shareholders from Janus Henderson will likely see their shares sold to Trian Fund Management and General Catalyst, with a cash offer of $49.00 per share on the table. This deal will be analyzed thoroughly by Monteverde & Associates to ensure all stockholder interests are adequately represented.

Shareholder Rights and Actions

Monteverde & Associates has been recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report and operates out of the iconic Empire State Building in New York City. Attorney Juan Monteverde emphasizes that not all law firms are the same when it comes to representing shareholder interests. The firm invites affected shareholders from the companies in question to engage without any cost or obligation, ensuring they understand their rights and the implications of these transactions.

The firm’s approach focuses not only on litigation but also on fostering ongoing communication with shareholders about their rights. Those with concerns regarding these mergers or seeking more information are encouraged to reach out directly via the firm’s website or directly via email or phone.

Call to Action

With shareholder votes scheduled for April 16, 2026, this is a crucial time for stockholders of DAWN, SEM, FONAR, and JHG. Actions taken now could significantly impact the financial returns of these proposed transactions. In addition to the immediate financial implications, these investigations can serve as a timely reminder of the ongoing importance of shareholder rights and representation in corporate transactions.

For any shareholders interested in learning more about their rights or the implications of the proposed mergers, Monteverde & Associates is ready and available to assist in this critical juncture. Contact attorney Juan Monteverde at (212) 971-1341 or via email at [email protected]. Protecting the interests of shareholders lies at the heart of Monteverde & Associates' mission, making their services invaluable during these significant corporate changes.